These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9678778)

  • 1. High prebeta1-HDL levels in hypercholesterolemia are maintained by probucol but reduced by a low-cholesterol diet.
    Miida T; Yamaguchi T; Tsuda T; Okada M
    Atherosclerosis; 1998 May; 138(1):129-34. PubMed ID: 9678778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prebeta1-high-density lipoprotein (prebeta1-HDL) concentration can change with low-density lipoprotein-cholesterol (LDL-C) concentration independent of cholesteryl ester transfer protein (CETP).
    Miida T; Ozaki K; Murakami T; Kashiwa T; Yamadera T; Tsuda T; Inano K; Okada M
    Clin Chim Acta; 2000 Feb; 292(1-2):69-80. PubMed ID: 10686277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probucol markedly reduces HDL phospholipids and elevated prebeta1-HDL without delayed conversion into alpha-migrating HDL: putative role of angiopoietin-like protein 3 in probucol-induced HDL remodeling.
    Miida T; Seino U; Miyazaki O; Hanyu O; Hirayama S; Saito T; Ishikawa Y; Akamatsu S; Nakano T; Nakajima K; Okazaki M; Okada M
    Atherosclerosis; 2008 Oct; 200(2):329-35. PubMed ID: 18279878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition.
    McPherson R; Hogue M; Milne RW; Tall AR; Marcel YL
    Arterioscler Thromb; 1991; 11(3):476-81. PubMed ID: 1903061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer.
    Matsuzawa Y; Yamashita S; Funahashi T; Yamamoto A; Tarui S
    Am J Cardiol; 1988 Jul; 62(3):66B-72B. PubMed ID: 3394656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of high-density lipoprotein reduction after probucol treatment: changes in plasma cholesterol esterification/transfer and lipase activities.
    Chiesa G; Michelagnoli S; Cassinotti M; Gianfranceschi G; Werba JP; Pazzucconi F; Sirtori CR; Franceschini G
    Metabolism; 1993 Feb; 42(2):229-35. PubMed ID: 8474321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bezafibrate increases prebeta 1-HDL at the expense of HDL2b in hypertriglyceridemia.
    Miida T; Sakai K; Ozaki K; Nakamura Y; Yamaguchi T; Tsuda T; Kashiwa T; Murakami T; Inano K; Okada M
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2428-33. PubMed ID: 11073848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of probucol on plasma lipids, lipoproteins and parameters of high density lipoprotein metabolism.
    Wetterau JR; Combs KA; Albers HW; Lamkin G; Stein EA; Barnhart RL; Chi EM; Jackson RL; Harmony JA
    Horm Metab Res; 1992 Jun; 24(6):289-96. PubMed ID: 1634195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose tissue cholesteryl ester transfer protein mRNA in response to probucol treatment: cholesterol and species dependence.
    Quinet EM; Huerta P; Nancoo D; Tall AR; Marcel YL; McPherson R
    J Lipid Res; 1993 May; 34(5):845-52. PubMed ID: 8509722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite effects on serum cholesteryl ester transfer protein levels between long-term treatments with pravastatin and probucol in patients with primary hypercholesterolemia and xanthoma.
    Inazu A; Koizumi J; Kajinami K; Kiyohar T; Chichibu K; Mabuchi H
    Atherosclerosis; 1999 Aug; 145(2):405-13. PubMed ID: 10488970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of vitamin E and HMG-CoA reductase inhibition on cholesteryl ester transfer protein and lecithin-cholesterol acyltransferase in hypercholesterolemia.
    Napoli C; Leccese M; Palumbo G; de Nigris F; Chiariello P; Zuliani P; Somma P; Di Loreto M; De Matteis C; Cacciatore F; Abete P; Liguori A; Chiariello M; D'Armiento FP
    Coron Artery Dis; 1998; 9(5):257-64. PubMed ID: 9710685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hepatic HDL-related mRNAs on plasma prebeta HDL in cholesterol-fed rabbits.
    Sugano M; Makino N; Yanaga T
    Artery; 1997; 22(4):182-205. PubMed ID: 9576025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia. Effects on apolipoprotein AI-containing lipoprotein particles.
    Adlouni A; El Messal M; Saïle R; Parra H; Fruchart J; Ghalim N
    Atherosclerosis; 2000 Oct; 152(2):433-40. PubMed ID: 10998472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probucol treatment in hypercholesterolemic patients: effects on lipoprotein composition, HDL particle size, and cholesteryl ester transfer.
    Bagdade JD; Kaufman D; Ritter MC; Subbaiah PV
    Atherosclerosis; 1990 Oct; 84(2-3):145-54. PubMed ID: 2282096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
    Artery; 1993; 20(1):1-18. PubMed ID: 8447724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoproteins from probucol-treated patients have increased capacity to promote cholesterol efflux from mouse peritoneal macrophages loaded with acetylated low-density lipoproteins.
    Ishigami M; Yamashita S; Sakai N; Hirano K; Arai T; Maruyama T; Takami S; Koyama M; Kameda-Takemura K; Matsuzawa Y
    Eur J Clin Invest; 1997 Apr; 27(4):285-92. PubMed ID: 9134376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LCAT-dependent conversion of prebeta1-HDL into alpha-migrating HDL is severely delayed in hemodialysis patients.
    Miida T; Miyazaki O; Hanyu O; Nakamura Y; Hirayama S; Narita I; Gejyo F; Ei I; Tasaki K; Kohda Y; Ohta T; Yata S; Fukamachi I; Okada M
    J Am Soc Nephrol; 2003 Mar; 14(3):732-8. PubMed ID: 12595510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probucol normalizes cholesteryl ester transfer in IDDM.
    Bagdade JD; Stein E; Ritter MC
    Diabetes Care; 1995 Oct; 18(10):1341-6. PubMed ID: 8721935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of HDL metabolism by probucol in complete cholesteryl ester transfer protein deficiency.
    Noto H; Kawamura M; Hashimoto Y; Satoh H; Hara M; Iso-o N; Togo M; Kimura S; Tsukamoto K
    Atherosclerosis; 2003 Nov; 171(1):131-6. PubMed ID: 14642415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.